Has William Gray, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,256,937 in general payments to William Gray, MD across 1,370 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Gray, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Gray, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Gray, MD

Interventional Cardiology · Wynnewood, PANPI 1720165640

Payments from drug & device makers

$3,256,937in general payments, 2019–2025

Across 1,370 payments — averaging $2377.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$2.2M
Medtronic$223K
Boston Scientific$214K
Philips North America LLC$200K
W. L. Gore & Associates, Inc.$136K
Shockwave Medical, Inc$81K
plus $241K from 36 others

$300,015in research payments, 2019–2025

Across 54 payments — averaging $5555.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Contego Medical, Inc$270K
Inspiremd Ltd$20K
Medtronic$8K
Terumo Medical Corporation$2K

What the payments were for

Consulting fees$524,02670%
Speaking & faculty fees$84,76211%
Travel & lodging$87,30012%
Food & beverage$30,5154%
Ownership interest$26,7004%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	390	$2,161,805
Medtronic(2 entities)	216	$223,234
Boston Scientific	360	$214,134
Philips North America LLC	129	$200,003
W. L. Gore & Associates, Inc.	88	$136,206
Shockwave Medical, Inc	23	$80,783
Abbott	54	$63,269
Surmodics, Inc.	13	$53,199
Contego Medical, Inc	4	$26,857
Intact Vascular, Inc.	13	$24,072
Cardiovascular Systems Inc.	3	$19,092
Bard Peripheral Vascular, Inc.	1	$12,500
Baylis Medical Company Inc	7	$8,694
Penumbra, Inc.	2	$8,400
Cordis US CORP.	6	$8,217
Cagent Vascular Inc	4	$5,284
Endologix LLC	8	$4,068
Reflow Medical Inc	2	$2,130
Microvention, Inc.	1	$2,000
Inspiremd Ltd	6	$854
Siemens Medical Solutions USA, Inc.	7	$649
Mercator Medsystems, Inc.	1	$271
Heartflow, Inc.	3	$209
AbbVie	2	$207
Centerline Biomedical Inc.	3	$125
Devoro Medical Inc.	1	$104
Johnson & Johnson	1	$100
E.r. Squibb & Sons, L.L.C.	3	$77
Novo Nordisk	2	$54
Acist Medical Systems, Inc.	1	$43
Pfizer	3	$40
Getinge USA Sales, LLC	2	$39
Imperative Care, Inc	1	$35
Vesper Medical	1	$33
Abiomed	1	$27
AstraZeneca	2	$23
Boehringer Ingelheim	1	$20
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$20
Terumo Medical Corporation	1	$17
Teleflex LLC	1	$16
Biosense Webster, Inc.	1	$14
Amgen	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

(9520) IGT Devices Undivided$171,418
Product in Development$86,412
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$41,750
GORE VIABAHN Endoprosthesis with Heparin$39,028
Vascular Lithotripsy$39,000
VIATORR Endoprosthesis$38,860
GORE PROPATEN Vascular Graft$35,008
GENERAL - THERAPIES$27,455
SurVeil$26,975
VersaCross Access Solution$26,091
Tack Endovascular System$24,000
IN.PACT Admiral$23,309
GORE VIABAHN Endoprosthesis$23,053
GORE-TEX Vascular Graft$19,305
GORE-TEX Stretch Vascular Graft$16,248
GORE ACUSEAL Vascular Graft$16,248
Spectranetics Undiv$13,636
(6554) Peripheral Vascular Undivided$11,168
GORE VIABAHN VBX Balloon Expandable Endo$10,733
AngioJet Ultra 5000A$10,625

How this compares

$3,256,937 in reported general payments places this provider in the 95th percentile of 281 interventional cardiology providers in Pennsylvania.

See all interventional cardiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$28,975

Medicare patients

Services billed

120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	17	$237
Amlodipine Besylate	21	$165
Rosuvastatin Calcium	11	$141
Losartan Potassium	13	$110
Isosorbide Mononitrate ErIsosorbide Mononitrate	12	$50

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Wynnewood

Eric GnallWynnewood$2.4M
Paul CoadyWynnewood$431K
Timothy ShapiroWynnewood$246K
Howard HerrmannPhiladelphia$2.2M
Ramzi KhalilPittsburgh$1.6M
Nishant SethiScranton$1.3M
Matthew BeckerErie$1.3M
David LasordaPittsburgh$1.1M
Nainesh PatelAllentown$1.1M
Jay GiriPhiladelphia$1M

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →